Medications Development for the Treatment of Alcohol Use Disorder (U01 Clinical Trial Optional)

The summary for the Medications Development for the Treatment of Alcohol Use Disorder (U01 Clinical Trial Optional) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Medications Development for the Treatment of Alcohol Use Disorder (U01 Clinical Trial Optional): The purpose of this Funding Opportunity Announcement (FOA) is to invite cooperative agreement applications for research that advances promising compounds thorough the drug development pipeline for the treatment of Alcohol Use Disorder (AUD). NIAAA is seeking applications for medications development research projects from both for-profit and not-for-profit entities, including academic institutions, pharmaceutical and biotechnology companies, private and public foundations, small businesses not eligible for the SBIR/STTR program and single entities able to demonstrate significant resource commitment to the proposed project. A resource commitment from a single entity could, for example, consist of salary support for key personnel or production and formulation of clinical trial material. The aim of this FOA is to move candidate compounds through Investigational New Drug (IND) requirements, Phase 1 human safety, tolerability, and dosing studies, and Phase 2 human laboratory and proof-of-concept trials. Within these phases of drug development, each proposed project should have a defined entry and exit point. Finally, this FOA will not support animal studies to prove efficacy of the candidate compound unless required by the Food and Drug Administration or peer review. Applicants are strongly encouraged to contact the NIAAA Division of Medications Development Staff prior to submitting to this FOA.
Federal Grant Title: Medications Development for the Treatment of Alcohol Use Disorder (U01 Clinical Trial Optional)
Federal Agency Name: National Institutes of Health (HHS-NIH11)
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-AA-19-005
Type of Funding: Cooperative Agreement
CFDA Numbers: 93.273
CFDA Descriptions: Information not provided
Current Application Deadline: February 11th, 2019
Original Application Deadline: February 11th, 2019
Posted Date: November 15th, 2018
Creation Date: November 15th, 2018
Archive Date: March 19th, 2019
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Last Updated: November 15th, 2018
Applicants Eligible for this Grant
State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For-profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification.)
Additional Information on Eligibility
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Link to Full Grant Announcement
http://grants.nih.gov/grants/guide/rfa-files/RFA-AA-19-005.html
Grant Announcement Contact
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Similar Government Grants
Comprehensive Alcohol-HIV/AIDS Research Center (P60 Clinical Trial Optional)
HEAL Initiative: Justice Community Opioid Innovation Network (JCOIN) Methodology and Advan...
HEAL Initiative: Justice Community Opioid Innovation Network (JCOIN) Coordination and Tran...
HEAL Initiative: Justice Community Opioid Innovation Network (JCOIN) Clinical Research Cen...
Alcohol-HIV/AIDS Program Project (P01 Clinical Trial Optional)
Mechanisms of Alcoholic Pancreatitis
Alcohol Abuse and Hiv/Aids in Resource-Poor Societies
Mechanisms of Alcohol-Induced Tissue Injury
More Grants from the National Institutes of Health
NIDCR Mentoring Network to Support a Diverse Dental, Oral and Craniofacial Research Workfo...
Graduate Research Training Initiative for Student Enhancement (G-RISE) (T32)
Physical Sciences-Oncology Network (PS-ON): Physical Sciences-Oncology Projects (PS-OP) (U...
Center without Walls for PET Ligand Development for Alzheimer's disease related dementias ...
Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2018 FederalGrants.com